BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9393198)

  • 1. Encephalopathy after transjugular intrahepatic portosystemic shunting: analysis of incidence and potential risk factors.
    Zuckerman DA; Darcy MD; Bocchini TP; Hildebolt CF
    AJR Am J Roentgenol; 1997 Dec; 169(6):1727-31. PubMed ID: 9393198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage.
    Sahagun G; Benner KG; Saxon R; Barton RE; Rabkin J; Keller FS; Rosch J
    Am J Gastroenterol; 1997 Sep; 92(9):1444-52. PubMed ID: 9317060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of percutaneous intrahepatic portosystemic shunt on splanchnic and systemic hemodynamics in patients with portal hypertension].
    François E; García-Pagán JC; Bru C; Feu F; Gilabert R; Escorsell A; Bosch J; Rodés J
    Gastroenterol Hepatol; 1997 Jan; 20(1):1-4. PubMed ID: 9072189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transjugular intrahepatic portosystemic shunts in hemodialysis-dependent patients and patients with advanced renal insufficiency: safety, caution, and encephalopathy.
    Haskal ZJ; Radhakrishnan J
    J Vasc Interv Radiol; 2008 Apr; 19(4):516-20. PubMed ID: 18375295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Factors for Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt in Patients with Hepatocellular Carcinoma and Portal Hypertension.
    Yao J; Zuo L; An G; Yue Z; Zhao H; Wang L; Liu F
    J Gastrointestin Liver Dis; 2015 Sep; 24(3):301-7. PubMed ID: 26405702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between pre-TIPS hepatic hemodynamics and postoperative incidence of hepatic encephalopathy.
    Deng D; Liao MS; Qin JP; Li XA
    Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):232-6. PubMed ID: 16698582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of transjugular intrahepatic portosystemic shunt induced refractory hepatic encephalopathy with the parallel technique: results of a clinical follow-up study.
    Maleux G; Heye S; Verslype C; Nevens F
    J Vasc Interv Radiol; 2007 Aug; 18(8):986-92; quiz 993. PubMed ID: 17675616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
    Colombato L
    J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.
    Riggio O; Nardelli S; Moscucci F; Pasquale C; Ridola L; Merli M
    Clin Liver Dis; 2012 Feb; 16(1):133-46. PubMed ID: 22321469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurophysiological evidence of cognitive impairment in patients without hepatic encephalopathy after transjugular intrahepatic portosystemic shunts.
    Kramer L; Bauer E; Gendo A; Funk G; Madl C; Pidlich J; Gangl A
    Am J Gastroenterol; 2002 Jan; 97(1):162-6. PubMed ID: 11808942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Transjugular intrahepatic portosystemic shunt and combination with percutaneous transhepatic or transsplenic approach for the treatment of portal vein thrombosis with or without cavernomatous transformation].
    Han GH; Meng XJ; Yin ZX; Wang JH; He CY; Liang J; Guo XG; Liu J; Ding L; Wu KC; Fan DM
    Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(22):1549-52. PubMed ID: 19953883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Portosystemic pressure gradient during transjugular intrahepatic portosystemic shunt with Viatorr stent graft: what is the critical low threshold to avoid medically uncontrolled low pressure gradient related complications?
    Chung HH; Razavi MK; Sze DY; Frisoli JK; Kee ST; Dake MD; Hellinger JC; Kang BC
    J Gastroenterol Hepatol; 2008 Jan; 23(1):95-101. PubMed ID: 18171347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunts: incidence and risk factors.
    Somberg KA; Riegler JL; LaBerge JM; Doherty-Simor MM; Bachetti P; Roberts JP; Lake JR
    Am J Gastroenterol; 1995 Apr; 90(4):549-55. PubMed ID: 7717309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of transjugular intrahepatic portosystemic shunt through the left branch vs. the right branch of the portal vein in advanced cirrhosis: a randomized trial.
    Chen L; Xiao T; Chen W; Long Q; Li R; Fang D; Wang R
    Liver Int; 2009 Aug; 29(7):1101-9. PubMed ID: 19386025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transjugular intrahepatic portosystemic shunts in liver transplant recipients for management of refractory ascites: clinical outcome.
    Saad WE; Darwish WM; Davies MG; Waldman DL
    J Vasc Interv Radiol; 2010 Feb; 21(2):218-23. PubMed ID: 20123207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transjugular intrahepatic portosystemic shunt: early experience with a flexible trocar/catheter system.
    Maynar M; Cabrera J; Pulido-Duque JM; Reyes R; Górriz E; Rostagno R; Ferral H; Castañeda-Zúñiga WR
    AJR Am J Roentgenol; 1993 Aug; 161(2):301-6. PubMed ID: 8333367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of transjugular intrahepatic portosystemic shunt (TIPS) on quantitative liver function tests.
    Baron A; Gulberg V; Sauter G; Waggershauser T; Reiser M; Gerbes AL
    Hepatogastroenterology; 1998; 45(24):2315-21. PubMed ID: 9951915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transjugular intrahepatic portosystemic shunt does not alter cerebral blood flow.
    Iversen P; Keiding S; Mouridsen K; Ott P; Vilstrup H
    Clin Gastroenterol Hepatol; 2011 Nov; 9(11):1001-3. PubMed ID: 21806953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Portosystemic shunt via the left branch of portal vein for the prevention of encephalopathy following transjugular intrahepatic portosystemic shunt].
    Chu J; Sun X; Piao L; Chen Z; Huang H; Lu C; Xu J
    Zhonghua Gan Zang Bing Za Zhi; 2002 Dec; 10(6):437-40. PubMed ID: 12502447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined TIPS with portal-azygous disconnection improved the long term clinical outcome in portal hypertension patients.
    Wu X; Han J; Cao J; Wu X; Li W; Sun J; Li J
    J Hepatobiliary Pancreat Surg; 2009; 16(6):858-64. PubMed ID: 19789834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.